Life and death in the genesis of the tumour cell

Toxicology Letters

Volumn 102-103, Issue , 1998, Pages 115-119

  Harrison, David J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Apoptosis; Cell cycle; Colon; Liver; Lymphoma; p53; Tumorigenesis

Indexed keywords

CARCINOGEN; MITOGENIC AGENT; PROTEIN P53; TOXIC SUBSTANCE;

APOPTOSIS; CELL CYCLE; CELL DEATH; CELL SPECIFICITY; CONFERENCE PAPER; DNA DAMAGE; DOSE RESPONSE; GENE EXPRESSION REGULATION; HUMAN; INTESTINE CANCER; LIVER CARCINOGENESIS; LYMPHOMA; MUTATION; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; SUPPRESSOR GENE; TUMOR CELL;

APOPTOSIS; CELL DIVISION; DNA DAMAGE; HUMANS; INTESTINAL NEOPLASMS; LIVER NEOPLASMS; LYMPHOMA; NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032422626     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(98)00295-1     Document Type: Conference Paper

References (16)

1. Canman, C.E., Kastan, M.B., 1997. Apoptosis in the pathogenesis and treatment of cancer. In: Kaufmann, S.H. (Ed.), Apoptosis. Pharmacological Implications and Their Therapeutic Opportunities. Academic Press, San Diego, pp. 1-34.
2. Bellamy, C.O.C., Clarke, A.R., Wyllie, A.H., Harrison, D.J., 1997. p53 deficiency in liver reduces local control of survival and proliferation, but does not affect apoptosis after DNA damage. FASEB J. 11, 591-599.
3. Clarke, A.R., Cummings, M.C., Harrison, D.J., 1995. Interaction between murine germ line mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy. Oncogene 11, 1913.
4. Clarke, A.R., Howard, L.A., Harrison, D.J., Winton, D.J., 1997. p53, mutation frequency and apoptosis in the murine small intestine. Oncogene 14, 2015-2018.
5. Clarke, A.R., Purdie, C.A., Harrison, D.J., et al., 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362, 849-851.
6. Evan, G.I., Wyllie, A.H., Gilbert, C.S., et al., 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119-127.
7. Griffiths, S.D., Clarke, A.R., Healy, L.E., et al., 1997. Absence of p53 permits propagation of mutant cells following genotoxic damage. Oncogene 14, 523-531.
8. Howie, S.E.M., Harrsion, D.J., Wyllie, A.H., 1994. Lymphocyte apoptosis - mechanisms and implications in disease. Immunol. Rev. 142, 141-156.
9. Malcomson, R.D.G., Oren, M., Wyllie, A.H., Harrison, D.J., 1995. p53-independent death, and p53-induced protection against apoptosis, in fibroblasts treated with chemotherapeutic drugs. Br. J. Cancer 72, 952.
10. McCaughan, F.M., Brown, A.L., Harrison, D.J., 1994. The effect of inhibition of glutathione S-transferase P on the growth of the Jurkat human T cell line. J. Pathol. 172, 357-362.
11. Frost, S., Bellamy, C.O.C., Cunningham, D.S., Harrison, D.J., 1998. Altered DNA repair and dysregulation of p53 in IRF-1 null hepatocytes. FASEB J. 12, 181-188.
12. Purdie, C.A., Harrison, D.J., 1994. Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene 9, 603-609.
13. Webb, S.J., Harrison, D.J., Wyllie, A.H., 1997. Apoptosis: An overview of the process and its relevance in disease. In: Kaufmann, S.H. (Ed.), Apoptosis. Pharmacological Implications and Their Therapeutic Opportunities. Academic Press, San Diego, pp. 1-34.
14. White, E., 1993. Regulation of apoptosis by the transforming genes of the DNA tumor virus adenovirus. Proc. Soc. Exp. Med. Biol. 254, 30-38.
15. Wyllie, A.H., 1994. Death gets a brake. Nature 369, 272-273.
16. Yonish-Rouach, E., Grunwald, D., Wilder, S., et al., 1993. p53-Mediated cell death - relationship to cell cycle control. Mol. Cell. Biol. 13, 1415-1423.